Julie Gagnaire
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 10
- SARS-CoV-2 and COVID-19 Research 3
- Clostridium difficile and Clostridium perfringens research 3
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 5
-
- Antibiotic Resistance in Bacteria 3
-
- Streptococcal Infections and Treatments 4
-
- COVID-19 and Mental Health 3
-
- Infective Endocarditis Diagnosis and Management 3
- Co-authors
- Élisabeth Botelho-NeversP. BerthelotBruno PozzettoPaul O. VerhoevenFlorence GrattardF. LuchtAnne CarricajoAmandine Gagneux‐Brunon
- Partner nations
- FranceBrazilSaudi Arabia
In The Last Decade
Julie Gagnaire
19 papers receiving 366 citations
Peers
Comparison fields: 5 of 78
- Infectious Diseases 247
- Clinical Biochemistry 88
- Microbiology 29
- Applied Microbiology and Biotechnology 9
- Molecular Medicine 18
Countries citing papers authored by Julie Gagnaire
This map shows the geographic impact of Julie Gagnaire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Gagnaire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Gagnaire more than expected).
Fields of papers citing papers by Julie Gagnaire
This network shows the impact of papers produced by Julie Gagnaire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Gagnaire. The network helps show where Julie Gagnaire may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Julie Gagnaire, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 7 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 9 | |
| 4 | 2022 | 15 | |
| 5 | 2022 | 2 | |
| 6 | 2020 | 19 | |
| 7 | 2020 | 4 | |
| 8 | 2020 | 12 | |
| 9 | 2019 | 13 | |
| 10 | 2017 | 8 | |
| 11 | 2017 | 28 | |
| 12 | 2016 | 15 | |
| 13 | 2016 | 10 | |
| 14 | 2016 | 1 | |
| 15 | 2015 | 53 | |
| 16 | 2015 | 7 | |
| 17 | 2015 | 1 | |
| 18 | 2015 | 9 | |
| 19 | 2013 | 97 | |
| 20 | 2012 | 62 |
About Julie Gagnaire
Julie Gagnaire is a scholar working on Infectious Diseases, Clinical Biochemistry and Molecular Medicine, having authored 20 papers that have together received 372 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (10 papers), Bacterial Identification and Susceptibility Testing (5 papers), Streptococcal Infections and Treatments (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Antibiotic Resistance in Bacteria (3 papers), COVID-19 and Mental Health (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers) and Infective Endocarditis Diagnosis and Management (3 papers). The work is most often cited by research in Infectious Diseases (247 citations), Clinical Biochemistry (88 citations) and Microbiology (29 citations). Julie Gagnaire has collaborated with scholars based in France, Brazil and Saudi Arabia. Frequent co-authors include Élisabeth Botelho-Nevers, P. Berthelot, Bruno Pozzetto, Paul O. Verhoeven, Florence Grattard, F. Lucht, Anne Carricajo, Amandine Gagneux‐Brunon, François Vandenesch and Carole Pélissier.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.